Posted by AGORACOM-JC
at 4:32 PM on Friday, February 28th, 2020
AGORACOM Clients Attending PDAC 2020
THEREGAL PROJECT
B.C.’s Next Premier
Silver, Lead, Zinc, Copper Deposit?
Affinity Metals holds under option, a 100% interest in the Project, located within the northern end of the prolific Kootenay Arc, a highly prospective mineralized trend.
Treaty Creeks’ GOLDSTORM zone hosts a conceptual volume of ONE BILLION TONNES rock grading close to one gram per tonne gold and is open to the north, east, and at depth. Â
A major drill program is being planned for spring to develop a resource calculation. The focus has been on the gold enriched Goldstorm Zone which is on trend with, and part of, the same geological system as Seabridge Gold’s neighboring KSM deposits.
American Creek been selected to do a formal presentation at the conference. The presentation will be held on Tuesday, March 5 at 2:00PM in room #802
HPQ Silicon Resources designs, develops, manufactures and commercializes plasma base processes
The innovative PUREVAP “Quartz Reduction Reactors†(QRR), will permit the One Step transformation of Quartz (SiO2) into High Purity Silicon (Si) at prices that will promote considerable renewable energy potential.
Lomiko hosts high-grade graphite at its La Loutre Property in Quebec. The company is working toward a Pre-Economic Assessment (PEA) that will increase its current indicated resource of 4.1 Mt of 6.5% Cg to over 10 Mt of 10%+ Cg in order to supply and develop graphite materials for the green economy.
30% Of Acquisition Price Paid If Venom Revenues Hit $30,000,000 and $40,000,000 By DEC 31, 2021
Average revenue per gram YTD 2019 $CDN 14 and will continue to increase as vape cartridge mix grows ($CDN 30 per gram)
One Of Arizona’s Largest Producers Of Award-Winning Medical Cannabis Distillate
Acquisition Expected To Close By March 31, 2020 Subject To Due Diligence
An established brand in Arizona for high quality
products in the wholesale and distillate marketplace. Venom is
leveraging its brand and success to aggressively expand into other US
states.
ACQUISITION TERMS
Hollister will acquire Venom Extracts for CDN$20,000,000 via Hollister stock
The stock price will be determined based on the greater of:
The 14-day VWAP (Volume Weighted Average Price) capped at $0.25 subsequent to announcing the transaction and $0.20
Once share price is established, 70% of the Payment Shares will be issued upon closing of the transaction
Remaining
30% of the Payment Shares will be issued when and if the following
milestones have been met on or prior to December 31st, 2021
Posted by AGORACOM-JC
at 3:29 PM on Thursday, February 27th, 2020
Announced the launch of its redesigned website taking effect this March
Website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested partiesÂ
MONTREAL, Feb. 27, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is proud to announce the launch of its redesigned website taking effect this March. The website has been revamped to include new features and improved functionality that provide instant access to essential information and features geared towards PyroGenesis’ interested parties. Â
PyroGenesis’ new website will be continuously updated with business
developments, events, company presentations, media mentions and press
releases. Once launched, visitors are encouraged to explore the website
and sign up for direct emails from the Company.
“We are happy to unveil our redesigned website which offers a clean
and modern design providing a more comprehensive understanding of
PyroGenesis’ technologies,” said Mr. P Peter Pascali, CEO and President
of PyroGenesis. “We believe that this website will allow our visitors to
have a very informative experience as we continue to grow and increase
our market presence. I trust the timing of this news release is not lost
on our readers.â€
Of note, it is possible that, during this transition, PyroGenesis’
website may be under maintenance for a period up to 24 hours. It is also
important to note that, during the weeks following the launch date, the
redesigned website may be experiencing some minor technical
adjustments. PyroGenesis’ team will work diligently to ensure all issues
are resolved in a timely manner. The company looks forward to hearing
your comments and feedback.
About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in
the design, development, manufacture and commercialization of advanced
plasma processes and products. We provide engineering and manufacturing
expertise, cutting-edge contract research, as well as turnkey process
equipment packages to the defense, metallurgical, mining, advanced
materials (including 3D printing), oil & gas, and environmental
industries. With a team of experienced engineers, scientists and
technicians working out of our Montreal office and our 3,800 m2
manufacturing facility, PyroGenesis maintains its competitive advantage
by remaining at the forefront of technology development and
commercialization. Our core competencies allow PyroGenesis to lead the
way in providing innovative plasma torches, plasma waste processes,
high-temperature metallurgical processes, and engineering services to
the global marketplace. Our operations are ISO 9001:2015 and AS9100D
certified, and have been since 1997. PyroGenesis is a publicly-traded
Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR)
and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from
time-to-time in the Corporation’s ongoing filings with the securities
regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com.
Actual results, events, and performance may differ materially. Readers
are cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws. Neither the TSX Venture Exchange, its
Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) nor the OTCQB accepts responsibility for the
adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
For further information please contact:
Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected]
Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
Recently launched CBD extraction facility
First extraction system capacity = 2,300 Kg per year.
CBD based products are poised to be a $20B global industry by 2022
Medical cannabis is poised to be a $100B global industry by 2025
Company to Create Psilocybin and Psychadelics Division Leveraging Corporate Wellness Clinics and Franchise Clinic Network
CBD consumption to rise across the treatment of neurological conditions
Research shows that CBD consumption for the treatment of neurological conditions is set to rise.
With an exponential rise in the availability of CBD products and public opinion towards it becoming more positive over the past decade, the consumption of the ingredient has exploded.
Global Market Insights, Inc., forecasts that global cannabidiol market size will be worth more than $89bn by 2026.
However, the industry will need to overcome the complex regulatory
landscape as well as quality and supply challenges in the near future.
Over the past few years, cannabidiol, or CBD, has caught the public’s
imagination as an ingredient presenting a range of health benefits when
infused in various consumables. More and more individuals worldwide are
now vouching for its effectiveness in terms of alleviating certain
chronic illnesses and treating several health conditions.
CBD has conquered industry after industry, from pharmaceuticals to
personal care and cosmetics, food and beverages, and nutraceuticals.
Cannabidiol is the legal and non-psychoactive counterpart of
tetrahydro cannabidiol (THC), the chemical compound responsible for
cannabis’s psychological effects. CBD is the second most-commonly used
active ingredients of cannabis.
The cannabinoid is derived directly from the hemp plant, a cousin of
the cannabis plant, and forms an essential component of medical
cannabis.
CBD regulatory landscape in Europe
Factors such as population growth, nationalised healthcare, GDP, and
cultural historic use of CBD in many European countries make the
continent an attractive market for global producers of both medical and
retail cannabis-based products. Hemp cultivation in the region has
witnessed a massive upsurge in recent years; the European Union (EU)
constitutes more than 25% of the global hemp production.
In July last year Epidiolex CBD oil
received a positive recommendation for marketing approval from the
European Medicines Agency (EMA) for the treatment of seizures. EMA’s
Human Medicines Committee (CHMP) approved the oral solution for use with
clobazam for the treatment of seizures associated with Dravet syndrome
or Lennox-Gastaut syndrome in patients aged two or more.
The European Commission granted marketing approval to Epidyolex, the
trade name for Epidiolex in Europe, in September 2019. Epidiolex is the
only federally-approved CBD product in the U.S.
Additionally, the use of CBD in cosmetics is harmonised within the European Cosmetic Regulation 1223/2009.
The regulation prohibits the use of cannabis and its derivatives in
cosmetic products. Essentially, EU prohibits the use of CBD derived
naturally from cannabis plants. However, the use of hemp-derived or
synthetically-produced cannabidiol is approved.
Europe CBD market is poised to witness monumental growth in the
forthcoming years on account of surging consumer demand for
safe-strength CBD products that are easily available in their normal
retail environments and cultivated, extracted, processed and labelled as
per the European standards.
Growing burden of neurological diseases in Europe
Europe has witnessed a growing occurrence of various neurological
conditions in recent years. These include epilepsy, migraine, stress,
anxiety, and numerous sleeping disorders. An expanding geriatric
population base indicates rising incidences of these conditions. Citing
data from the European Brain Council, more than 220 million people in Europe
suffer from at least one neurological condition, which is more than the
populations of France, Germany, and the Great Britain combined.
Described below are some of the most prevalent neurological
conditions in Europe and the effectiveness of CBD in their treatment.
Stress and anxiety – Nearly 25% of the European population suffers
from stress, anxiety or depression each year. The effectiveness of CBD
products as anti-anxiety nutraceuticals is backed with plenty of
research, however there is still a long way to go. Several clinical
trials have provided considerable evidence of cannabidiol’s usefulness
for the treatment of generalised anxiety disorder (GAD), post-traumatic
stress disorder (PTSD), obsessive-compulsive disorder (OCD), social
anxiety disorder, and panic disorder;
Migraine – Migraine currently affects more than 11% of the global
population. The social societal burden of migraine in Europe is an
approximately €27bn
per year. While pain medications are known to help temporarily
alleviate the symptoms of migraine, they can have several side-effects.
Research concerning the use of cannabidiol for migraine is limited
however a number of laboratory studies suggest that CBD oil may help
reduce all types of acute and chronic pain, including migraine; and
Seizures – In Europe, close to six. million people suffer from
epilepsy, while 15 million people will have at least one seizure at some
point during their lifetime. Numerous research studies over the years
have demonstrated the benefits and effectiveness of hemp-derived CBD
products in patients with epilepsy who have not responded to traditional
treatment.
Surging popularity of cannabidiol among boomers along with ongoing
research and development into its potential health benefits will augment
CBD market forecast. More and more boomers are adding CBD to their
health regimes to help reduce stress and anxiety, get better sleep, and
alleviate chronic pain. Increasing awareness towards the safety and
efficacy of cannabidiol products will drive future CBD industry trends.
Posted by AGORACOM
at 9:21 AM on Thursday, February 27th, 2020
Cardston, Alberta–(February 27, 2020) – American Creek Resources
Ltd. (TSXV: AMK) (“the Corporation”) is pleased to report the assays
from phase 1 drilling from the 2019 fall drill program that was
conducted at the company’s 100% owned Dunwell Mine property located in
the Golden Triangle of British Columbia.
The Dunwell Mine is a high-grade past producing polymetallic mine
located just 8km by road from the shipping town of Stewart. This
property boasts exceptional logistics and a rich mining history with
significant potential for future development. A significant geological
feature running through the property is the Portland Canal Fissure Zone.
With the recent acquisition of the Glacier Creek claims American Creek
now controls 5km of the 6.5km Portland Canal Fissure Zone which contains
numerous high-grade polymetallic mineral occurrences including two past
producing mines (the Dunwell and Portland Canal). Very little modern
exploration has been done on the property. While there is huge potential
exploring along the extended reaches of the fissure zone, the initial
drill program was designed to test areas near the workings of the
Dunwell mine itself.
The initial objective for the drill program was to test the down dip
extension of the Dunwell main vein below sub-level 4. The second
objective was to test geophysical anomalies from an Induced Polarization
(IP) survey conducted later in the fall of 2019. Both of these
objectives were successfully accomplished with this drill program.
A total of 20 holes totaling 3,245.9m were completed on the property.
The first 14 holes were based on geological and historical data and
were successful in encountering veins of high-grade polymetallic
mineralization including 20.3 g/t AuEq over 2.7m, 18.4 g/t AuEq over 1.5m, 28.6 g/t AuEq over 0.5m and 24.4 g/t AuEq over 0.5m.
Holes DW19-04 to DW19-08 were drilled to test the down dip of the Dunwell zone below sub-level 4.
Results show high-grade hits, including 13.2 g/t AuEq,
in this series of holes that traversed from the east southeast to the
east. The holes consistently hit two zones, both at the base of dikes at
22 – 26 meters and 83 – 87 meters. These two zones, seen in the five
holes, run sub-parallel to the fault the drill pad was located on and
trend for some distance to the north.
Hole DW19-09 was drilled to test the north extension of the main zone
below level 4. The first breccia below the dike shows up in this hole
with a 28.5 g/t AuEq assay and the second with a 18.4 g/t AuEq assay.
HOLE
FROM (m)
TO (m)
INTERVAL (m)
AU g/t
AG g/t
CU %
PB %
ZN %
AuEq g/t
DW19-09
27.60
28.05
0.45
13.870
258.0
0.438
15.530
11.040
28.509
DW19-09
143.02
144.52
1.50
7.898
84.9
0.359
0.791
20.250
18.440
Hole DW19-10 was drilled to test below sub-level 4 but further to the southeast from hole DW19-04.
HOLE
FROM (m)
TO (m)
INTERVAL (m)
AU g/t
AG g/t
CU %
PB %
ZN %
AuEq g/t
DW19-10
29.00
29.57
0.57
2.785
42.5
0.055
0.713
3.020
4.956
DW19-10
88.71
89.61
0.90
3.535
43.2
0.060
1.480
2.860
5.959
DW19-10
99.13
99.79
0.66
1.707
33.7
0.031
0.285
0.529
2.491
The two breccias below the dikes, seen in holes 7 and 8 are present.
Holes 11 to 13 were drilled to follow up on the results from hole 9.
The holes were drilled in a fan where holes 11 and 12 were drilled at a
steeper angle to test below hole 9 and hole 13 was drilled at a flatter
angle to test above hole 9. Hole 14 was drilled at a 5° rotation to the
north of hole 9 to test the width of the structure.
HOLE
FROM (m)
TO (m)
INTERVAL (m)
AU g/t
AG g/t
CU %
PB %
ZN %
AuEq g/t
DW19-11
26.82
27.82
1.00
5.601
66.0
0.213
1.700
7.850
10.729
DW19-11
95.63
96.27
0.64
4.408
34.5
0.026
0.363
0.757
5.326
DW19-11
138.45
138.95
0.50
4.026
66.0
0.166
1.070
6.220
8.139
DW19-11
142.24
144.93
2.69
11.346
142.5
0.220
3.197
13.069
20.269
DW19-12
22.17
23.47
1.30
2.851
60.8
0.147
1.844
4.946
6.638
DW19-12
27.05
27.81
0.76
1.562
30.4
0.104
0.647
2.660
3.461
DW19-12
97.49
99.15
1.66
1.546
54.4
0.041
1.060
5.356
4.998
DW19-13
27.55
28.15
0.60
8.110
113.0
0.171
4.630
8.270
15.116
DW19-13
142.87
143.57
0.70
4.486
66.6
0.068
0.710
1.009
6.087
DW19-14
27.43
28.23
0.80
8.924
161.0
0.309
5.120
6.800
16.222
DW19-14
98.32
99.86
1.54
7.692
32.8
0.009
0.207
0.111
8.227
DW19-14
142.75
144.70
1.95
3.720
43.2
0.103
0.755
9.240
8.673
DW19-14
146.88
147.38
0.50
9.403
264.0
0.528
5.210
20.900
24.347
All the holes intersected the breccia below the dike at about 27
meters. Holes 11, 13 and 14 appear to intersect a similar structure to
that seen in hole 9. Multiple high-grade intercepts assayed as high as 24.3 g/t AuEq, 20.3 g/t AuEq, 16.3 AuEq, and 15.1 g/t AuEq while the remaining intercepts were still strong.
No modern exploration techniques or technologies have been used on
the Dunwell until a cutting edge Induced Polarization (IP) survey took
place in late fall of 2019. Only two of the dozens of geophysical
anomalies identified in the survey in close proximity to the Dunwell
Mine were drill tested in this first phase of drilling.
The last 6 holes (DW19-15 to DW19-19) were drilled to test the extent
of a large IP anomaly and were successful in encountering veins of
high-grade polymetallic mineralization including 19.4 g/t AuEq over 3.6m, 38.1 g/t AuEq over 0.5m and 28.4 AuEq over 0.4m with the remaining intercepts also containing significant mineralization.
Hole 15 was drilled south into the anomaly and Hole 16 was drilled
west into the anomaly with both intersecting a massive sulphide zone.
Holes 17 – 19 were drilled in a fan to follow up hole 16. Hole 18 also
hit a massive sulphide zone.
HOLE
FROM (m)
TO (m)
INTERVAL (m)
AU g/t
AG g/t
CU %
PB %
ZN %
AuEq g/t
DW19-15
100.90
102.08
1.18
8.445
869.0
0.034
0.186
1.265
19.536
DW19-15
152.09
152.59
0.50
32.230
472.0
0.008
0.134
0.372
38.119
DW19-16
45.11
45.81
0.70
11.260
144.0
0.208
6.550
6.010
18.471
DW19-16
75.07
78.68
3.61
8.850
88.8
0.221
1.768
19.514
19.354
DW19-17
no significant results
DW19-18
38.79
39.22
0.43
15.300
185.0
2.874
2.870
14.470
28.243
DW19-19
34.87
36.04
1.17
3.332
27.9
0.048
0.986
2.580
5.239
DW19-19
75.71
77.13
1.42
5.255
225.9
0.159
9.298
3.315
13.328
Hole 16 hit a massive sulphide interval at 75 – 78 meters. Hole 20
was drilled to test an IP anomaly along the access road below the second
drill pad. One small breccia was intercepted.
HOLE
FROM (m)
TO (m)
INTERVAL (m)
AU g/t
AG g/t
CU %
PB %
ZN %
AuEq g/t
DW19-20
121.01
121.45
0.44
1.669
27.5
0.007
0.034
0.082
2.056
CEO and President, Darren Blaney stated: “Our very
first drill program has intersected a significant number of high-grade
veins in the vicinity of the mine workings confirming our belief in the
potential of this project.
The Dunwell is an incredibly prospective property located in the
heart of the Golden Triangle. It has everything going for it from
amazing logistics to past high-grade production, with all indications
being that there is substantive additional ore yet to be mined.
With the recent acquisition of the Glacier Creek Crown Grants we now
cover 5km of the heavily mineralized Portland Canal Fissure Zone which
runs for 6.5km and is associated with over a dozen high-grade gold and
silver showings including two past producing mines. The potential of the
property extends far beyond the old workings of the Dunwell Mine.
Future exploration will be using the latest technologies to aid us in
unlocking that potential.”
Through a series of strategic acquisitions American Creek was able to
purchase the past-producing Dunwell Mine as well as several adjoining
very prospective properties, combining them into one large land package
that encompasses the best gold and silver mineral occurrences and
historic workings in the Bear River valley. The amalgamated property
spans 2,222 hectares covering the majority of the Portland Canal Fissure
Zone, an area first prospected in the late 1800’s and hosting some of
the earliest producing gold and silver mines in the Stewart area.
The Dunwell project is located 8km northeast of Stewart and is road
accessible with the Dunwell Mine adit itself located only 2km from
Highway 37A and a major power line. Stewart hosts a deep sea port
including ore loading and shipping facilities. Unlike the majority of
mineral properties located near Stewart, the Dunwell is located in low
mountainous terrain (700 m and lower elevation) with moderate relief.
These features allow for year-round work which typically isn’t the case
for exploration programs conducted in the Stewart region where projects
are typically at higher altitude, are accessible only by helicopter, and
lack critical infrastructure such as roads and power. The Dunwell
project may just have the best logistics of any project in the Golden
Triangle.
The Dunwell Mine is the most significant mineral occurrence within
the Portland Canal Fissure Zone. Production at the Dunwell occurred
between 1926 and 1937. From historic reports, it appears that a total of
45,657 tonnes averaging 6.63 g/t gold, 223.91 g/t silver, 1.83% lead,
2.43% zinc and 0.056% copper were produced.
In addition to the Dunwell mine itself, the property package also
contains over a dozen other high-grade gold and silver occurrences and
historic small-scale gold/silver high-grading operations along a
north/south trend that correlates to the fissure zone and major
faulting. Some examples of the nine areas that actually produced ore
are:
Ben Ali: 4,500 tons at 21.6 g/t gold
Lakeview 60 tons at 4.7 g/t gold, 2,734 g/t silver, and 11.5% lead
Victoria 11 tons at 20.15 g/t gold, 775 g/t silver, 25% lead
Tyee 8.2 tons at 124.4 g/t gold and 4,478.8 g/t silver
George E 12 tons at 13 g/t gold and 3,250 g/t silver, 23.3% lead
Each of these areas were producing during the 1930’s when exploration
techniques and technology was very primitive. American Creek has
already started to use the latest in exploration technology on the
property and will continue to do so to unlock the great potential that
exists here.
The Qualified Person for the Dunwell results in this new release is
James A. McCrea, P. Geo., for the purposes of National Instrument
43-101. He has read and approved the scientific and technical
information that forms the basis for the disclosure contained in this
news release.
About American Creek
American Creek holds a strong portfolio of gold and silver properties
in British Columbia. The portfolio includes three Golden Triangle
gold/silver properties; the Treaty Creek and Electrum joint ventures
with Walter Storm/Tudor as well as the 100% owned past-producing Dunwell
Mine. Other properties held throughout BC include the Gold Hill,
Austruck-Bonanza, Ample Goldmax, Silver Side, and Glitter King.
For further information please contact Kelvin Burton at: Phone: 403 752-4040 or Email: [email protected]. Information relating to the Corporation is available on its website at www.americancreek.com
Posted by AGORACOM
at 9:10 AM on Thursday, February 27th, 2020
Stillcanna is a vertically integrated, European-based company
with a focus on industrial-scale manufacturing of the highest quality
CBD extracts
Stillcanna looks to become one of the largest producers of THC-free CBD extracts in Europe
VANCOUVER, BC / ACCESSWIRE / February 26, 2020 / Mota Ventures Corp. (CSE:MOTA)(OTC:PEMTF)(FRANKFURT:1WZGR) (“Mota“) and Stillcanna Inc. (STIL)(SCNNF)(A2PEWA) (“Stillcanna“) are pleased to announce that they have entered into a letter of intent (the “Letter of Intent“),
dated effective February 25, 2020, pursuant to which Mota proposes to
acquire all of the outstanding share capital of Stillcanna (the “Proposed Transaction“).
Strategic Merger
Mota
is a globally-focused CBD product development and marketing company
with established online retail brands in both the U.S. and Europe.
Through its acquisition of First Class CBD, Mota has become a
significant direct-to-consumer retail brand in the United States. In
2019, First Class CBD (then, a division of Unified Funding, LLC)
realized approximately C$28.7 million in revenue with an EBITDA of
approximately 12.5%.1 Mota’s successful e-commerce platform currently
serves over 140,000 online customers and has generated over 400,000
leads in the United States. With the roll-out of First Class CBD’s
proven e-marketing strategy throughout Europe, Mota believes that a
merger with a high-quality CBD producer is of paramount importance in
order to capture the large margins in the CBD-product supply chain.
Stillcanna
is a vertically integrated, European-based company with a focus on
industrial-scale manufacturing of the highest quality CBD extracts.
Using proprietary extraction techniques and purpose-built equipment,
Stillcanna looks to become one of the largest producers of THC-free CBD
extracts in Europe. Stillcanna’s Polish extraction facility, NEXUS, features
industrial-scale centrifugal chromatography equipment that allows for
the production of bulk THC-free CBD distillate as well as custom
Cannabinoid profiles. In February 2020, Stillcanna’s Romanian extraction
facility, ORIGIN,
which operates pursuant to a joint venture between Stillcanna and
Dragonfly Biosciences Ltd., received approval from the Ministry of
Health and the Anti-Drug Agency to become the first government
recognized extraction facility in the country. To date C$23,000,000 has
been invested by Stillcanna in the cultivation and extraction
operations, with current cash on hand in Stillcanna of approximately
C$7,000,000.
Stillcanna’s
CBD extracts are key to unlocking additional value in Mota’s retail
offerings in Europe. Through Stillcanna, Mota hopes to guarantee the
supply of high-quality CBD for its expanding product line in Europe,
while the large production capacity of NEXUS and ORIGIN will allow Mota to be a key supplier of legal CBD products in Europe.
“We
are very excited to pursue a transaction with Stillcanna. The merger of
this large-scale, high-quality CBD producer will fit brilliantly with
Mota’s strategic expansion plan to vertically integrate operations in
Europe while increasing profit margins in product offerings. Product
awareness and availability are still quite limited in Europe, which
presents an opportunity for Mota to further establish its brands in a
market that is expected to experience rapid growth in the near term.
With the Stillcanna merger, we’re putting together a team that can
create, market and sell consumer CBD products to European customers,â€
stated Ryan Hoggan, CEO of Mota.
“Combining
a company that has established brands and direct-to-consumer sales
channels with one that has proven CBD extraction expertise makes perfect
sense to us,†commented Jason Dussault, CEO of Stillcanna. “The
wholesale landscape for CBD has changed dramatically in the past year,
and the creation of a seed-to-consumer CBD company in the growing
European market creates a direct path to profitability. This merger
completes the circle for Stillcanna, evolving from a seed to CBD
concentrate company to a seed to retail sales company.â€
Merger Details
Under
the terms of the Proposed Transaction, Mota would acquire all of the
outstanding share capital of Stillcanna by way of a statutory plan of
arrangement under the Business Corporations Act of British Columbia Canada. Shareholders of Stillcanna (the “Stillcanna Shareholders“) would receive one common share of Mota for every 1.8 common shares of Stillcanna held at the time of exchange (the “Exchange Ratio“).
Based on the current outstanding common share capital of Stillcanna, it
is anticipated that Mota would issue approximately 61,597,082 Mota
shares to complete the Proposed Transaction.
Upon
completion of the Proposed Transaction: (i) all outstanding incentive
stock options of Stillcanna will be exchanged for options to purchase
Mota shares on the basis of the Exchange Ratio and will thereafter be
subject to the incentive stock option plan of Mota; and (ii) all
unexercised share purchase warrants of Stillcanna will be exchanged for
warrants to purchase Mota shares on the basis of the Exchange Ratio and
will expire in accordance with their current expiry dates.
Mota
and Stillcanna are at arms-length. The Proposed Transaction does not
constitute a reverse-takeover of Mota, nor is it expected to result in a
change of control of Mota within the meaning of applicable securities
laws and the policies of the Canadian Securities Exchange. Upon
completion of the Proposed Transaction, there will be no changes to the
management or the board of directors of Mota and it is expected that
members of management and the board of Stillcanna will continue to
assist in relation to the management of Stillcanna’s business.
Completion
of the Proposed Transaction remains subject to a number of conditions,
including, but not limited to: (i) satisfactory completion of due
diligence; (ii) negotiation of definitive, legally-binding
documentation; (iii) receipt of any required regulatory approvals,
including the court; (iv) the approval of the Stillcanna Shareholders;
(v) receipt of a satisfactory fairness opinion in respect of the
Proposed Transaction; (vi) Stillcanna having arranged to amend the terms
of certain existing employment and consulting engagements; (vii)
shareholders of Stillcanna holding at least 40,000,000 of the
outstanding share capital of Stillcanna having agreed to the terms of a
pooling arrangement restricting their ability to trade one-half of the
Mota shares they receive for a period of six months following completion
of the Proposed Transaction; (viii) Stillcanna having positive working
capital of not less than C$6,000,000, after taking into account all
expenses associated with the Proposed Transaction; and (ix) Mota
completing a private placement of units to raise gross proceeds of not
less than C$5,000,000 (the “Mota Financing“).
The Proposed Transaction cannot be completed until these conditions are
satisfied. There can be no assurance that the Proposed Transaction will
be completed as proposed or at all.
The
proposed Mota Financing will consist of units at a price of C$0.45 per
unit, with each unit comprised of one Mota common share and one share
purchase warrant of Mota. Each such warrant will be exercisable to
purchase one common share of Mota at a price of C$0.60 for a period of
two years. All securities to be issued in connection with the Mota
Financing will be subject to a four-month-and-one-day statutory hold
period in accordance with applicable securities laws. Mota anticipates
paying finders fees to certain eligible parties who have introduced
subscribers to the Mota Financing.
The
board of directors of each of Mota, and Stillcanna, have unanimously
approved the Letter of Intent. Further information about the Proposed
Transaction will be included in subsequent press releases when
available.
About Mota Ventures Corp.
Mota
is seeking to become a vertically integrated global CBD brand. Its plan
is to cultivate and extract CBD into high-quality value-added products
from its Latin American operations and distribute it both domestically
and internationally. Its existing operations in Colombia consist of a
2.5-hectare site that has optimal year-round growing conditions and
access to all necessary infrastructure. Mota is looking to establish
sales channels and a distribution network internationally through the
acquisition of the Sativida and First Class CBD brands. Low cost
production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
About Stillcanna Inc.
Stillcanna
is a Canadian early-stage life sciences company focused on the
large-scale manufacturing of CBD in Europe using its proprietary
intellectual property. Stillcanna has signed an initial extraction
contract in Europe to be the exclusive extractor for Dragonfly
Biosciences LLC, a United Kingdom-based supplier of CBD. Stillcanna also
recently completed the acquisition of Olimax NT SP.Z.O.O., a
multi-generational hemp agricultural firm that is expected to increase
market share in the European CBD industry.
Posted by AGORACOM
at 8:45 AM on Thursday, February 27th, 2020
The Wollammo product consists of 100% St-Onge Wollastonite
A premium grade natural Wollastonite mineral product that helps to increase plant available silicon, calcium and magnesium in soils and enhance plant stress tolerance, increase yields and improve pest management for a variety of agricultural crops.
VERTICAL EXPLORATION INC. (TSXV:VERT) (“Vertical”or “the Company”) is pleased to provide an update regarding its recent, highly encouraging, test marketing and customer awareness efforts for the Company’s high-quality St-Onge Wollastonite.
Vertical’s
distribution partner, Wollammo Distribution Inc. (Wollammo), received
significant positive interest in its Wollammo product at the 2020 BC
Home and Garden Show that took place at BC Place Stadium in Vancouver
from February 19th – 23rd. The Wollammo product, which consists of 100%
St-Onge Wollastonite, is a premium grade natural Wollastonite mineral
product that helps to increase plant available silicon, calcium and
magnesium in soils and enhance plant stress tolerance, increase yields
and improve pest management for a variety of agricultural crops.
The
prestigious BC Home and Garden Show has been a staple in British
Columbia consumers’ calendars since 1971, attracting more than 50,000
plus qualified visitors each year which makes it one of the largest home
and garden shows in the province. The 2020 Show featured high-interest
exhibits, high-profile industry personalities and the latest home,
garden and lifestyle trends. The Wollammo Distribution team was one of
over 400 exhibitors, hosting a high profile vendor booth at the event.
Throughout
the five day Show, the Wollammo team received an excellent response
from event patrons for the St-Onge based Wollammo product – the team
provided over 3800 test market Wollammo packaged samples to interested
home, garden and larger agricultural customers which far exceeded its
initial estimate of 2000 samples for the entire event. Thousands more
consumers also visited the booth to specifically touch, feel and find
out more about the Wollammo product and its valuable agricultural uses.
Matt
Harvey, Director of Wollammo Distribution Inc., commented: “My team and
I were simply overwhelmed by the positive response we received at the
BC Home and Garden show regarding our premium Wollammo product. The
people and businesses that visited our booth were very eager to learn
about all the numerous plant health benefits of the natural
calcium-silicate rich St-Onge Wollastonite. The Wollammo test market
samples literally flew off our display shelves – we now have hundreds of
new customers and enquiries to follow-up on in the days and weeks
ahead, including a large range of agricultural companies and wholesale
businesses that want to further test and potentially purchase our
Wollammo product as soon as possible.”
Peter
P. Swistak, President/CEO of Vertical Exploration Inc., also commented:
“I was personally at the Show, working alongside Matt and his excellent
team, to help provide up to date information about our premium St-Onge
Wollastonite to the thousands of interested people and also the retail
and wholesale businesses that visited our booth. The BC Home and Garden
Show has been an unqualified success for our Company and the Wollammo
brand, and it bodes extremely well for our plans to move quickly ahead
with our Quebec quarry permitting process and on to future sales to a
wide range of agricultural and cannabis customers following that.”
Vertical
anticipates providing further updates regarding the numerous test
market opportunities and partnerships, that both the Company and its
Wollammo Distribution partner are currently following up on, that have
arisen as a result of attending the 2020 BC Home and Garden Show in
Vancouver.
ABOUT VERTICAL EXPLORATION
Vertical
Exploration’s mission is to identify, acquire, and advance high
potential mining prospects located in North America for the benefit of
its stakeholders. The Company’s flagship St-Onge Wollastonite property
is located in the Lac-Saint-Jean area in the Province of Quebec.
ON BEHALF OF THE BOARD Peter P. Swistak, President/CEO
Posted by AGORACOM
at 6:10 PM on Wednesday, February 26th, 2020
Stillcanna is a vertically integrated, European-based company with a focus on industrial-scale manufacturing of the highest quality CBD extracts
Stillcanna looks to become one of the largest producers of THC-free CBD extracts in Europe
VANCOUVER, BC / ACCESSWIRE / February 26, 2020 /Â Mota Ventures Corp. (CSE:MOTA)(OTC:PEMTF)(FRANKFURT:1WZGR) (“Mota“) and Stillcanna Inc. (STIL)(SCNNF)(A2PEWA) (“Stillcanna“) are pleased to announce that they have entered into a letter of intent (the “Letter of Intent“), dated effective February 25, 2020, pursuant to which Mota proposes to acquire all of the outstanding share capital of Stillcanna (the “Proposed Transaction“).
Strategic Merger
Mota
is a globally-focused CBD product development and marketing company
with established online retail brands in both the U.S. and Europe.
Through its acquisition of First Class CBD, Mota has become a
significant direct-to-consumer retail brand in the United States. In
2019, First Class CBD (then, a division of Unified Funding, LLC)
realized approximately C$28.7 million in revenue with an EBITDA of
approximately 12.5%.1 Mota’s successful e-commerce platform currently
serves over 140,000 online customers and has generated over 400,000
leads in the United States. With the roll-out of First Class CBD’s
proven e-marketing strategy throughout Europe, Mota believes that a
merger with a high-quality CBD producer is of paramount importance in
order to capture the large margins in the CBD-product supply chain.
Stillcanna
is a vertically integrated, European-based company with a focus on
industrial-scale manufacturing of the highest quality CBD extracts.
Using proprietary extraction techniques and purpose-built equipment,
Stillcanna looks to become one of the largest producers of THC-free CBD
extracts in Europe. Stillcanna’s Polish extraction facility, NEXUS, features
industrial-scale centrifugal chromatography equipment that allows for
the production of bulk THC-free CBD distillate as well as custom
Cannabinoid profiles. In February 2020, Stillcanna’s Romanian extraction
facility, ORIGIN,
which operates pursuant to a joint venture between Stillcanna and
Dragonfly Biosciences Ltd., received approval from the Ministry of
Health and the Anti-Drug Agency to become the first government
recognized extraction facility in the country. To date C$23,000,000 has
been invested by Stillcanna in the cultivation and extraction
operations, with current cash on hand in Stillcanna of approximately
C$7,000,000.
Stillcanna’s
CBD extracts are key to unlocking additional value in Mota’s retail
offerings in Europe. Through Stillcanna, Mota hopes to guarantee the
supply of high-quality CBD for its expanding product line in Europe,
while the large production capacity of NEXUS and ORIGIN will allow Mota to be a key supplier of legal CBD products in Europe.
“We
are very excited to pursue a transaction with Stillcanna. The merger of
this large-scale, high-quality CBD producer will fit brilliantly with
Mota’s strategic expansion plan to vertically integrate operations in
Europe while increasing profit margins in product offerings. Product
awareness and availability are still quite limited in Europe, which
presents an opportunity for Mota to further establish its brands in a
market that is expected to experience rapid growth in the near term.
With the Stillcanna merger, we’re putting together a team that can
create, market and sell consumer CBD products to European customers,”
stated Ryan Hoggan, CEO of Mota.
“Combining
a company that has established brands and direct-to-consumer sales
channels with one that has proven CBD extraction expertise makes perfect
sense to us,” commented Jason Dussault, CEO of Stillcanna. “The
wholesale landscape for CBD has changed dramatically in the past year,
and the creation of a seed-to-consumer CBD company in the growing
European market creates a direct path to profitability. This merger
completes the circle for Stillcanna, evolving from a seed to CBD
concentrate company to a seed to retail sales company.”
Merger Details
Under
the terms of the Proposed Transaction, Mota would acquire all of the
outstanding share capital of Stillcanna by way of a statutory plan of
arrangement under the Business Corporations Act of British Columbia Canada. Shareholders of Stillcanna (the “Stillcanna Shareholders“) would receive one common share of Mota for every 1.8 common shares of Stillcanna held at the time of exchange (the “Exchange Ratio“).
Based on the current outstanding common share capital of Stillcanna, it
is anticipated that Mota would issue approximately 61,597,082 Mota
shares to complete the Proposed Transaction.
Upon
completion of the Proposed Transaction: (i) all outstanding incentive
stock options of Stillcanna will be exchanged for options to purchase
Mota shares on the basis of the Exchange Ratio and will thereafter be
subject to the incentive stock option plan of Mota; and (ii) all
unexercised share purchase warrants of Stillcanna will be exchanged for
warrants to purchase Mota shares on the basis of the Exchange Ratio and
will expire in accordance with their current expiry dates.
Mota
and Stillcanna are at arms-length. The Proposed Transaction does not
constitute a reverse-takeover of Mota, nor is it expected to result in a
change of control of Mota within the meaning of applicable securities
laws and the policies of the Canadian Securities Exchange. Upon
completion of the Proposed Transaction, there will be no changes to the
management or the board of directors of Mota and it is expected that
members of management and the board of Stillcanna will continue to
assist in relation to the management of Stillcanna’s business.
Completion
of the Proposed Transaction remains subject to a number of conditions,
including, but not limited to: (i) satisfactory completion of due
diligence; (ii) negotiation of definitive, legally-binding
documentation; (iii) receipt of any required regulatory approvals,
including the court; (iv) the approval of the Stillcanna Shareholders;
(v) receipt of a satisfactory fairness opinion in respect of the
Proposed Transaction; (vi) Stillcanna having arranged to amend the terms
of certain existing employment and consulting engagements; (vii)
shareholders of Stillcanna holding at least 40,000,000 of the
outstanding share capital of Stillcanna having agreed to the terms of a
pooling arrangement restricting their ability to trade one-half of the
Mota shares they receive for a period of six months following completion
of the Proposed Transaction; (viii) Stillcanna having positive working
capital of not less than C$6,000,000, after taking into account all
expenses associated with the Proposed Transaction; and (ix) Mota
completing a private placement of units to raise gross proceeds of not
less than C$5,000,000 (the “Mota Financing“).
The Proposed Transaction cannot be completed until these conditions are
satisfied. There can be no assurance that the Proposed Transaction will
be completed as proposed or at all.
The
proposed Mota Financing will consist of units at a price of C$0.45 per
unit, with each unit comprised of one Mota common share and one share
purchase warrant of Mota. Each such warrant will be exercisable to
purchase one common share of Mota at a price of C$0.60 for a period of
two years. All securities to be issued in connection with the Mota
Financing will be subject to a four-month-and-one-day statutory hold
period in accordance with applicable securities laws. Mota anticipates
paying finders fees to certain eligible parties who have introduced
subscribers to the Mota Financing.
The
board of directors of each of Mota, and Stillcanna, have unanimously
approved the Letter of Intent. Further information about the Proposed
Transaction will be included in subsequent press releases when
available.
About Mota Ventures Corp.
Mota
is seeking to become a vertically integrated global CBD brand. Its plan
is to cultivate and extract CBD into high-quality value-added products
from its Latin American operations and distribute it both domestically
and internationally. Its existing operations in Colombia consist of a
2.5-hectare site that has optimal year-round growing conditions and
access to all necessary infrastructure. Mota is looking to establish
sales channels and a distribution network internationally through the
acquisition of the Sativida and First Class CBD brands. Low cost
production, coupled with international, direct to customer sales
channels will provide the foundation for the success of Mota.
About Stillcanna Inc.
Stillcanna
is a Canadian early-stage life sciences company focused on the
large-scale manufacturing of CBD in Europe using its proprietary
intellectual property. Stillcanna has signed an initial extraction
contract in Europe to be the exclusive extractor for Dragonfly
Biosciences LLC, a United Kingdom-based supplier of CBD. Stillcanna also
recently completed the acquisition of Olimax NT SP.Z.O.O., a
multi-generational hemp agricultural firm that is expected to increase
market share in the European CBD industry.
Posted by AGORACOM-JC
at 4:21 PM on Wednesday, February 26th, 2020
If you are a small cap CEO, Director or Investor Relations Officer in North America, my 23 minute interview with James Black of the Canadian Securities Exchange (CSE) is the most important podcast you will listen to in 2020. Not because I am the guest but because of what I have to say.
Why does what I say matter? AGORACOM surpassed 600 million page
views this year, we’re averaging over 4.5M views per month on Twitter
and we’ve served over 300 clients. As such, the powerful information
in this podcast comes from a deep understanding of both social media,
why small cap companies are failing at it and what the serious
implications are of that failure.
Make no mistake about it, this isn’t some generic social media
discussion. James and I go deep and I hit hard because that is what
good friends do. I’m sounding the alarm because of the massive
implications if I don’t.
The good news is that, if you are not an AGORACOM client, you can
turn this ship around but you have to do it now and that can only be
done by understanding why small caps are failing today.
I suggest that your entire management team listens to it and discusses it. Then let’s have a call to discuss what can be done.
The beauty of this audio format is you can listen to it at work or in
your car / subway to and from work. I’ve done the hard work
presenting this powerful information, all you have to do is press play.
Thank-you and I look forward to discussing this with you and
potentially working together in 2020. Our cashless and fully compliant
shares for services program should make the decision an easy one.
Posted by AGORACOM
at 1:13 PM on Wednesday, February 26th, 2020
SPONSOR: American Creek owns a 20% Carried Interest to Production at the Treaty Creek Project in the Golden Triangle. 2019’s first hole averaged of 0.683 g/t Au over 780m in a vertical intercept. The Treaty Creek property is located in the same hydrothermal system as the Pretivm and Seabridge’s KSM deposits. Click Here For More Info
Exchange-traded fund holdings expand for 25 days to most ever
Moody’s Analytics says recession possible if pandemic occurs
Global investors are stashing more and more assets into gold as the
coronavirus outbreak spreads and appetite for risk takes a hit.
The global tally of bullion in exchange-traded funds swelled by the
most in more than a month on Tuesday as equities sank. That was the 25th
consecutive day of inflows, a record. At 2,624.7 tons, the holdings are
the largest ever.
After surging 18% last year, gold has extended its rally in 2020,
with prices hitting the highest since 2013. The haven has been favored
as the virus outbreak has spread beyond China, threatening a pandemic
and slower growth.
Goldman Sachs Group Inc. has said that should the disruption from the disease stretch into the second quarter, prices may rally toward $1,850 an ounce. Spot bullion was last at $1,644.67, up 0.6%. It touched $1,689.31 on Monday.
A global recession
is likely if the coronavirus becomes a pandemic, according to Moody’s
Analytics Chief Economist Mark Zandi. The odds of that outcome now stand
at 40%, up from 20%, he said in a note.
The threat of a prolonged downturn in growth due to the impact of the virus may keep gold elevated, according to Morgan Stanley. Further ETF inflows are likely as long as real interest rates remain negative, it said in a note.
